A Novel TLR-9 Agonist C792 Inhibits Plasmacytoid Dendritic Cell-induced Myeloma Cell Growth and Enhance Cytotoxicity of Bortezomib

Our prior study in multiple myeloma (MM) patients showed increased numbers of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) which both contribute to immune dysfunction as well as promote tumor cell growth, survival, and drug resistance. Here we show that a novel Toll-Like Receptor (TLR...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ray, Arghya, Tian, Ze, Das, Deepika Sharma, Coffman, Robert L., Richardson, Paul, Chauhan, Dharminder, Anderson, Kenneth C.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4116471/
https://ncbi.nlm.nih.gov/pubmed/24476765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.46
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים